ACTOVEGIN ® 5ml Solution (200mg)
€25.00
ACTOVEGIN® 5ml Solution (200mg) is a deproteinized calf blood hemodialysate studied for its effects on neuroprotection, tissue regeneration, and wound healing. Research suggests potential benefits in ischemic conditions and metabolic function.
✓ Fast delivery
✓ Premium quality
✓ 3th party tested
In Stock
CompareDescription
ACTOVEGIN ® 5ml Solution (200mg)
Product Composition
- Total Volume: 5ml
- Actovegin Concentration: 40mg per ml
- Total Actovegin Content: 200mg
- Sodium Chloride Base: 134mg
Actovegin Research
Actovegin is a deproteinized hemodialysate derived from calf blood, which is thought to enhance cellular glucose and oxygen uptake. As a highly filtered extract, it is believed to improve aerobic oxidation in mammals, which may contribute to better glucose and oxygen absorption. Actovegin has been widely used in various regions, including Central Asia, East Asia, Russia, and parts of Europe, for research on neurological disorders, vascular health, and ischemic conditions.
Actovegin and Wound Healing
Studies indicate that Actovegin may support wound healing through its effects on tissue repair. Research has shown that:
- Actovegin enhances the reparation of wounds when compared to control treatments. Studies measuring wound healing properties, hydroxyproline concentration, and collagen ratios have suggested that Actovegin provides better healing outcomes than standard treatments.
- In animal models, Actovegin was found to accelerate skin wound healing by promoting hypervascularization and preventing scarring.
- When compared to collagen-based therapies, Actovegin exhibited similar wound healing capabilities, though through different biological mechanisms.
Actovegin and Neuroprotection
Actovegin has been explored in studies focused on neuroprotection, particularly in cases of ischemic stroke and traumatic brain injuries (TBI).
- In clinical settings, Actovegin has been used in combination with other neuroprotective agents such as Cerebrolysin and L-carnitine. Research involving patients with severe TBI and unresponsive wakefulness syndrome (UWS) indicated that those receiving Actovegin-based treatment protocols showed faster recovery compared to untreated groups.
- Actovegin’s potential neuroprotective effects are linked to its role in tissue repair and metabolism enhancement, which may support brain function in cases of neurological damage.
Actovegin and Tissue Regeneration
Actovegin has been examined for its potential in stimulating tissue regeneration in various biological systems.
- Research on bone regeneration found that Actovegin, in combination with osteoplastic materials, significantly promoted bone tissue healing.
- Studies on tissue repair following skin cryoablation in animal models demonstrated that Actovegin improved cell regeneration and accelerated wound closure.
Legal Disclaimer
This product is sold as a pure compound for research purposes only and is not intended for use as a dietary supplement. Please review our terms and conditions before purchasing.
Safety Information
Keep this product out of the reach of children. Research on Actovegin is ongoing, and improper handling may result in unintended effects. This product is for laboratory research only and is not for human or veterinary use.
We ensure the highest standards for product quality and description but are not responsible for improper handling or application.
The information provided is for educational and informational purposes only. This compound has not been evaluated by the FDA and is not intended to diagnose, prevent, or treat any medical condition.
